Antonio Serrano-Boza

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Galectin-3 shapes microglial phenotype through endogenous and exogenous mechanisms.

Galectin-3 shapes microglial phenotype through endogenous and exogenous mechanisms.

Journal: Frontiers in cellular neuroscience

Published: October 21, 2025

Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity.

Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 26, 2023

Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain.

Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain.

Journal: Neuropathology and applied neurobiology

Published: May 22, 2023

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.

Journal: Acta neuropathologica

Published: February 15, 2023

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.

Journal: Acta neuropathologica

Published: November 24, 2022

Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer's disease.

Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer's disease.

Journal: Translational neurodegeneration

Published: October 27, 2022

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease.

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease.

Journal: Acta neuropathologica

Published: February 22, 2022

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Journal: Molecular neurodegeneration

Published: January 31, 2022

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.

Journal: Cell death & disease

Published: December 01, 2021

Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner.

Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner.

Journal: Journal of neuroinflammation

Published: November 11, 2021

Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer's Disease.

Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: February 26, 2021

The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.

The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.

Journal: Brain, behavior, and immunity

Published: June 12, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026